{
    "diagnosis": {
        "final_diagnosis": "anaphylaxis after administration of ibritumomab tiuxetan",
        "differential_diagnosis": "Not specified",
        "diagnostic_reasoning": "The patient developed chest tightness, shallow respirations, hypotension, and incontinence immediately after receiving a therapeutic dose of Y-90 ibritumomab tiuxetan. His clinical presentation met the criteria for anaphylaxis, and an elevated human antimouse antibody (HAMA) level was found, indicating an immunologic response."
    }
}